Pathological tau reduced complex I activity, causing a reduction in ATP generation, mitochondrial membrane potential (ΔΨm) dissipation, promotion of mitochondrial fission and fragmentation and, finally, mitochondrial dysfunction in AD [53]. The gene discussed is MAPT; the disease is Alzheimer disease.